Register for More Information

Register Now

Find a Treatment Center

Enter your state or zip code to find a THERAKOSTM Photopheresis treatment center near you

Talk to your doctor to determine if treatment is right for you

 
 
 

Treatment of CTCL

Treatment of CTCL

How can CTCL be treated?

 

Once CTCL has been diagnosed, your doctor will consider both the stage of your disease and the symptoms you have, in order to determine the best treatment.

 

The goals of CTCL treatment are

  • To improve skin symptoms
  • To reduce redness and itching
  • To slow or halt the progression of the disease

CTCL treatments can generally be divided into 2 main categories:7

  • Therapies applied to the skin
  • Therapies administered in the entire body—by mouth, under the skin, or intravenously

In the past 2 decades, several new therapies have become available to treat CTCL.

Keep in mind, that no single therapy is effective in all patients. Only your doctor can determine which treatment is best for you and the order in which you receive these treatments. Your doctor may also prescribe multiple treatments, including those listed below, to treat your CTCL. This list is not comprehensive; some therapies may not be listed below.

 
 

Therapies applied to the skin

  • Ultraviolet (UV) phototherapy — A type of light is delivered to the skin to improve symptoms. This therapy can be administered either in a clinic or at home using a home light unit
    • Psoralen plus ultraviolet A (UVA) light (PUVA) — A medicine called a psoralen is given by mouth 90 minutes before UV phototherapy is begun. The medication makes the skin more sensitive to the light
  • Topical retinoids (bexarotene gel) — A gel-based medication is applied to the affected skin to improve symptoms and reduce disease activity
 

Entire body (systemic)

  • Bexarotene — These medications are related to vitamin A and are commonly used in addition to other therapies in skin diseases
  • Denileukin diftitox — This medication, administered by injection into a blood vessel, targets abnormal cells in order to reduce symptoms and disease activity
  • Extracorporeal photopheresis (ECP) with UVADEX® (methoxsalen) Sterile Solution — Blood is removed from the body and treated with a medication and UVA light in order to reduce symptoms and disease activity. Although the medicine and the light are administered outside your body, the treatment is considered systemic because the treated blood is subsequently returned to your body. THERAKOS™ Photopheresis is another name for ECP
  • Vorinostat — This medication, taken by mouth, has been shown to improve symptoms and reduce disease activity

 

 

Important Safety Information

Indications

Methoxsalen Sterile Solution is indicated for extracorporeal administration with the THERAKOS UVAR XTS® or THERAKOS CELLEX® Photopheresis System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.

Methoxsalen is not appropriate for patients who have had a reaction to psoralen compounds, patients who have had a light sensitive disease, or patients with an absence of one or both lenses of the eye.

THERAKOS Photopheresis is not appropriate for patients who cannot tolerate blood volume changes or patients with blood clotting disorders. See Important Safety Information for additional details.

 
 

All contents Copyright © Therakos, Inc. 2001-2013.

This site is published by Therakos, Inc. which is solely responsible for its contents.

It is intended for visitors from the United States of America.